专题：Pancreatic and Hepatic Oncology Research

This cluster of papers focuses on the research and treatment of pancreatic cancer, covering topics such as surgical complications, chemotherapy regimens (e.g., Gemcitabine), tumor microenvironment, genomic analyses, stromal biology, neoadjuvant therapy, and immunotherapy. The papers also discuss the impact of hospital volume on surgical outcomes and the prevalence of pancreatic cysts.
最新文献
Six-Color Multiplex Digital PCR Assays for Comprehensive Screening and Identification of Multiple Driver Mutations Associated with Pancreatic Carcinogenesis

article Full Text OpenAlex

Simvastatin in the prevention of recurrent pancreatitis: a triple-blinded randomised clinical trial (the SIMBA trial)

article Full Text OpenAlex

Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape

review Full Text OpenAlex

Advancing Therapeutic Strategies for Pancreatic Cancer: A Review of Surgical, Systemic and Diagnostic Innovations

article Full Text OpenAlex

Gut-to-tumor translocation of multidrug-resistant Klebsiella pneumoniae shapes the microbiome and chemoresistance in pancreatic cancer

article Full Text OpenAlex

A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance

article Full Text OpenAlex

Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms

article Full Text OpenAlex

Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study

article Full Text OpenAlex

Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial

article Full Text OpenAlex

LBA81 Final overall survival (OS) and the association of pathological outcomes with event-free survival (EFS) in MATTERHORN: A randomised, phase III study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric / gastroesophageal junction (G / GEJ) adenocarcinoma

article Full Text OpenAlex

近5年高被引文献
Cancer statistics, 2025

article Full Text OpenAlex 1828 FWCI2034.1878

Immune Checkpoint Inhibitors in Cancer Therapy

review Full Text OpenAlex 1182 FWCI117.8241

Pancreatic cancer: Advances and challenges

review Full Text OpenAlex 1075 FWCI257.0254

Immune checkpoint therapy—current perspectives and future directions

review Full Text OpenAlex 925 FWCI217.4871

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

article Full Text OpenAlex 922 FWCI296.1219

Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment

review Full Text OpenAlex 827 FWCI83.1884

TGF-β signaling in health, disease and therapeutics

review Full Text OpenAlex 798 FWCI192.1307

The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection

review Full Text OpenAlex 711 FWCI69.4876

TGF-β signaling in health and disease

review Full Text OpenAlex 685 FWCI107.9619

Management of Hepatocellular Carcinoma

review Full Text OpenAlex 678 FWCI142.2902